Premier Alternatives

Artios

Drug Discovery · Cambridge, United Kingdom · Founded 2015 · Privately Held (backing)

Developer of novel cancer treatments designed to target the deoxyribonucleic acid (DNA) damage response. Artios is based in Cambridge, United Kingdom and was founded in 2015. It was valued at $260 million at its later-stage round in Nov 2025, the last priced event on record. It has raised $385 million across 1 recorded round; the latest was an $114 million Series D in Nov 2025.

PMV mark · valuation
$260.3M
Oct 2026
Priced at
its later-stage round
Nov 2025
Total raised
$384.5M
Last round
Later Stage VC (Series D)
Nov 2025
How much has Artios raised?
$384.5Macross 1 recorded rounds · Nov 2025 – Nov 2025

Most recently, Artios raised $114.4M in its Later Stage VC (Series D) (Nov 2025).

Free account
More of Artios with a free account
  • ·The complete investor list: 27 names
  • ·Watch Artios: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Artios round by round

1 rounds
Nov 2025Later Stage VC (Series D)$114.4M▮
+ 1 more investors · free account

How much has Artios raised?

Artios has raised $385 million in total; 1 of its rounds is on record. The largest on record was an $114 million Series D in Nov 2025.

Artios investors

27 investors are on record for Artios, including RA Capital Management, Sofinnova Partners, M Ventures and The Invus Group. By type, the record holds 5 venture capital firms and 4 private equity firms. The Series D in Nov 2025 drew 15 investors.

For fundraisers
Raising for a company like Artios?

27 investors have backed Artios — start your target list with the firms already writing checks in drug discovery.

See all 27 investors →

Frequently asked about Artios

How much has Artios raised?
Artios has raised $384.5M in total across 1 recorded funding rounds.
When was Artios's last funding round?
Artios's most recent recorded round was Later Stage VC (Series D) in Nov 2025, raising $114.4M.